Complication and response assessment of high-dose-rate endorectal brachytherapy boost in neo-adjuvant chemoradiotherapy of locally advanced rectal cancer with long-term outcomes.

Arefeh Saeedian,Marzieh Lashkari,Reza Ghalehtaki,Maryam Taherioun,Mahdieh Razmkhah,Ali Kazemian,Mahdi Aghili

Journal of contemporary brachytherapy（2023）

引用 1|浏览0

暂无评分

摘要

Treatment schedule was well-tolerated, and neo-adjuvant HDR-BRT could achieve better T down-staging as a boost comparing with nCRT, without significant complication. However, the optimal dose and fractions in the context of HDR-BRT boost needs further studies.

查看译文

关键词

brachytherapy,neo-adjuvant chemoradiotherapy,boost,dose escalation,rectal cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要